Mildura Mayor Glenn Milne and Councillor Sharyon Peart formally launched the ASPREE (ASPirin in Reducing Events in the Elderly) study in the regional city recently. Over 50 ASPREE participants, their family, friends, GPs, practice managers and other interested parties attended the event at the Monash Regional Clinical School in Mildura. ASPREE Executive Officer, Associate Professor Robyn…Details
Medical Oncologist Dr Andrew Haydon, who oversees cancer aspects of a world-first aspirin trial, ASPREE, said that the recent association between aspirin and a reduced risk of developing melanoma was a call for closer investigation of aspirin’s anti-tumour effect. Melanoma is the most deadly form of skin cancer and is on the rise in Australia.…Details
The ASPREE (ASPirin in Reducing Events in the Elderly) study hosted a study update and morning tea at the Windsor Community Precinct on Friday 8th March to celebrate reaching 400 participants in the Launceston region. Special guest and Tamar Valley resident Peter Cundall – renowned horticulturalist and former host of the ABC program Gardening Australia –…Details
World-first Aspirin study reaches new milestone – 10,000 participants PRESS RELEASE: Melbourne, February 21 2013 – The largest primary prevention aspirin study ever undertaken in older people has reached an important milestone, signing up 10,000 participants in Australia. The landmark ASPREE (ASPirin in Reducing Events in the Elderly) study is investigating whether a daily low…Details
31 January 2013 To ASPREE participants and interested parties Recently you may have heard press reports that suggested aspirin might worsen an infrequent type of the eye disease called age – related macular degeneration or AMD. This is a condition of the eyes that in advanced cases causes severe vision loss. We write to reassure…Details
PRESS RELEASE Melbourne, January 23 2013 – Professor John McNeil, Head of Monash University’s Department of Epidemiology and Preventive Medicine and Lead Investigator of the ASPREE trial (pictured left) responds to the recent JAMA article study linking regular Aspirin Use and Age-Related Macular Degeneration (AMD): “The relationship between aspirin and AMD is complex and is…Details
ASPREE Principal Investigator, Professor John McNeil speaks to the Australian Ageing Agenda about the ASPREE study and the mixed messages about aspirin… “Professor McNeil said because aspirin is the most widely used drug in the world, there was a lot of media reporting of research related to a wide range of different effects associated with it.…Details
Outstanding GP support from regional GPs Local Wonthaggi girl, Dr Sharyn Fitzgerald recently travelled back to her home town to present plaques of appreciation to medical centres on behalf of a world-first international research study. More than 100 healthy people aged 70 and over from the Wonthaggi region have enrolled in the ASPREE (ASPirin in Reducing…Details
Manningham locals participate in Australia’s largest ever disease prevention trial The ASPREE (ASPirin in Reducing Events in the Elderly) study – the largest ever disease prevention aspirin trial to take place in Australia – is celebrating the participation of 250 Manningham residents who have signed up to the trial. The study will test whether taking…Details
Have you seen the ASPREE Community Service Announcement with Sir Gus Nossal? We are delighted to have the support of such a high profile and highly respected researcher.
ASPREE would like to sincerely thank Gus Nossal and Australian TV networks for airing this CSA.